6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Recurrent / Breakthrough ... DVT During Anticoagulation ... #VTE #anticoagulation ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... #Anticoagulation ... #Extension #VTE ... #DVT #Hematology ... Management #Diagnosis #Differential
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Isolated distal DVT ... Unprovoked proximal DVT ... PE - High Bleeding ... therapy - Second VTE ... management #hematology #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Avoid Warfarin and DOAC ... suggest prophylactic anticoagulation ... teratogenic GDMT meds ... Serial TTE and close